Shujian Wei
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology 2
- Pathology and Forensic Medicine top 10%
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Cardiovascular Function and Risk Factors 3
- Acute Myocardial Infarction Research 3
- Cardiovascular Disease and Adiposity 2
-
- Platelet Disorders and Treatments 2
-
- Cardiac Imaging and Diagnostics 2
-
- Adipose Tissue and Metabolism 2
Shujian Wei
21 papers receiving 484 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Biochemistry 61
- Pathology and Forensic Medicine 119
- Cancer Research 88
- Clinical Biochemistry 26
- Cardiology and Cardiovascular Medicine 86
Countries citing papers authored by Shujian Wei
This map shows the geographic impact of Shujian Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujian Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujian Wei more than expected).
Fields of papers citing papers by Shujian Wei
This network shows the impact of papers produced by Shujian Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujian Wei. The network helps show where Shujian Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shujian Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 9 | |
| 4 | The role of aldehyde dehydrogenase 2 in cardiovascular diseasebreakdown → | 2023 | 79 |
| 5 | 2023 | 6 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 2 | |
| 12 | 2019 | 41 | |
| 13 | 2018 | 11 | |
| 14 | 2016 | 39 | |
| 15 | 2012 | 22 | |
| 16 | 2012 | 23 | |
| 17 | 2011 | 33 | |
| 18 | [Research progress of poly (ADP-ribose) polymerase-1 in cardiac diseases]. | 2011 | 1 |
| 19 | 2010 | 115 | |
| 20 | 2005 | 13 |
About Shujian Wei
Shujian Wei is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine and Hematology, having authored 22 papers that have together received 488 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cardiovascular Function and Risk Factors (3 papers), Acute Myocardial Infarction Research (3 papers), Cardiovascular Disease and Adiposity (2 papers), Platelet Disorders and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Cardiac Imaging and Diagnostics (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Biochemistry (61 citations), Pathology and Forensic Medicine (119 citations) and Cancer Research (88 citations). Shujian Wei has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yuguo Chen, Xue Li, Panpan Hao, Haigang Wang, Yun Zhang, Jiali Wang, Jiali Wang, Feng Xu, Chang Pan and Mingxiang Zhang. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Frontiers in Immunology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.